Journals / Ege Pediatri Bülteni / 2005 / Cilt: 12 - Sayı: 3

The serum alpha-fetoprotein levels in the course of acute viral hepatitis

Akut viral hepatitlerin seyrinde serum alfa-fetoprotein düzeyleri

Pages
147–150
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, AFP can not be used as a follow-up marker in acute viral hepatitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study we aim to estimate the levels of alpha-fetoprotein (AFP) in the course acute viral hepatitis. 46 children diagnosed acute viral hepatitis in Harran University Hospital were included in this study.
📊
Key Findings & Data:Forty-two of the cases were diagnosed as hepatitis A and 4 as hepatitis B.
💡
Conclusion & Impact:As a result, AFP can not be used as a follow-up marker in acute viral hepatitis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study we aim to estimate the levels of alpha-fetoprotein (AFP) in the course acute viral hepatitis. 46 children diagnosed acute viral hepatitis in Harran University Hospital were included in this study. Forty-two of the cases were diagnosed as hepatitis A and 4 as hepatitis B. Twenty six were female, 20 male, mean age was 5,3±3,9 (range 1-14). In 8 children AFP levels were increased three weeks later. No significant correlation was found between serum levels of ALT, AST and bilurubin. Although AFP was above the cut-off level in 17.3% of the patients as a regeneration criteria, this was only a slight increase. As a result, AFP can not be used as a follow-up marker in acute viral hepatitis.

Özet

Akut viral hepatitlerin seyrinde alfa-fetoprotein'in (AFP) düzeyini ve gidişini araştırmak amacı ile, Harran Üniversitesi Tıp Fakültesi'ne başvuran ve akut viral hepatit A (n: 42) ve B (n: 4) saptanan 1-14 (5,3±3,9) yaşları arasında 46 çocuk [26 (%56.5) kız, 20 (%43.5) erkek] çalışmaya alındı. Hastalarda ilk gelişte bakılan AFP değeri 1.9±0.7 mg/dl, üç hafta sonra 5.1±3.9 olarak saptandı. AFP değeri 8 (%17.3) hastada cut-off değeri olan 10 mg/dl'nin üzerinde bulundu (12.7±2.3). AFP düzeyi yüksek saptanan ve saptanmayan hastalar arasında yaş, cinsiyet, hepatit tipi ve ALT, AST ve bilirubin düzeylerinin değişimi açısından istatistiki olarak anlamlı bir fark bulunmadı. Akut viral hepatitlerin seyrinde rejenerasyon kriteri olarak AFP başlangıştan üç hafta sonra hastaların %17.3'ünde cut-off değerinin üzerinde olmakla birlikte düşük düzeyde yükselmektedir. Bu sonuca göre akut viral hepatit olgularının izleminde AFP'nin yeri çok sınırlıdır.

🔖

Cite This Article

ZEYREK, D., ZEYREK, F., ERTAŞ, T., SEVİNÇ, E. (2022). The serum alpha-fetoprotein levels in the course of acute viral hepatitis. Ege Pediatri Bülteni, Cilt: 12 - Sayı: 3, 147–150. https://ajindex.com/articles/495773

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Wu JT, Book L, Sudar K. Serum alpha fetoprotein (AFP) levels in normal infants. Pediatr Res 1981; 15: 50-52. Johnson PJ. The Role of Serum Alpha-Fetoprotein estimation in the Diagnosis and Management of Hepatoceliular Carcinoma. Clin Liver Dis 2001; 5(1): 145-159.
  2. She WM, Hu DC, Yuan HJ, Zhai WR, Liang Y, Liu HY. Analysis of serum a-fetoprotein concentration in patients with viral hepatitis. Chinese J Dig Dis 2003; 4; 128-131. Kew MC. Tumor markers in hepatoceliular carcinoma. J Qastroenterol Hepatol 1989; 4: 373. Ravel R: Clinical Laboratory Medicine, 6th ed, Mosby-Year Book, 1995; 320. 25.Kreczko S, Lipska A, Wysocka J. Alpha-fetoprotein: diagnostic value in hepatic disorders. Pol Merkuriusz Lek 2000 Jun; 8(48): 420-423.
  3. Oka H, Tamori A, Kuroki T, et al. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatoceliular carcinoma. Hepatology 1994; 19: 61. Gerald J. Mizejewski. Alpha-fetoprotein Structure and Function: Relevance to Isoforms, Epitopes, and Conformational Variants. Exp Biol Med 2001; 226: 377-408.
  4. Johnson PJ, Poon TCW, Hjelm NM, Ho CS, Blake C, Ho SKW. Structures of disease-spesific serum alpha-fetoprotein isoforms. Br J Cancer 2000; 83: 1330.